What does Jasper Therapeutics, Inc. do?
Jasper Therapeutics, Inc., a clinical stage biotechnology company, focuses on the design and development of therapies to treat immune-mediated diseases. It is advancing a pipeline of medicines, including KP-104, a dual-complement inhibitor that has demonstrated positive outcomes in paroxysmal nocturnal hemoglobinuria…
What is Jasper Therapeutics, Inc.'s P/E and P/B ratio?
Jasper Therapeutics, Inc. has a P/E ratio of -0.5 and a P/B ratio of 11.67.
What is Jasper Therapeutics, Inc.'s debt-to-equity ratio?
Jasper Therapeutics, Inc. has a debt-to-equity ratio of 0.30.
How much does Jasper Therapeutics, Inc. owe compared with what it owns?
Jasper Therapeutics, Inc. owes $0.88 for every $1 it owns (balance sheet Jun 2026), which is high.
What is Jasper Therapeutics, Inc.'s Positivity rank?
Jasper Therapeutics, Inc. is ranked #5,801 of 6,774 companies globally and #3,224 of 4,000 in United States on PositoAI, with a Positivity Score of 15,185.
Does Jasper Therapeutics, Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
Yes. Jasper Therapeutics, Inc. has 1 active red flag (PosiRed) on record: Stock exchange listing-rule deficiency notice (8-K Item 3.01) (dated 09 Jun 2026). It has no yellow flags.
Where can I read the latest news about Jasper Therapeutics, Inc.?
Recent headlines about Jasper Therapeutics, Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does Jasper Therapeutics, Inc. have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of Jasper Therapeutics, Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.